Soluble guanylate cyclase: a potential therapeutic target for heart failure.
about
Cardiac endothelium-myocyte interaction: clinical opportunities for new heart failure therapies regardless of ejection fractionExtending the translational potential of targeting NO/cGMP-regulated pathways in the CVSThe cGMP signaling pathway as a therapeutic target in heart failure with preserved ejection fractionInsights into BAY 60-2770 Activation and S -Nitrosylation-Dependent Desensitization of Soluble Guanylyl Cyclase via Crystal Structures of Homologous Nostoc H-NOX Domain ComplexesPotential new drug treatments for congestive heart failure.Silent disease progression in clinically stable heart failure.Cyclic nucleotide signalling in kidney fibrosis.Left ventricular dysfunction with pulmonary hypertension: part 2: prognosis, noninvasive evaluation, treatment, and future research.Effect of asymmetric dimethylarginine (ADMA) on heart failure development.The NO/ONOO-cycle as the central cause of heart failure.Riociguat: first global approval.Vasodilators in Acute Heart Failure: Review of the Latest Studies.Small molecule and peptide therapies for chronic heart failure: a patent review (2011 - 2014).The Three-Decade Long Journey in Heart Failure Drug Development.New medical therapies for heart failure.From bedside to bench--meeting report of the 7th International Conference on cGMP "cGMP: generators, effectors and therapeutic implications" in Trier, Germany, from June 19th to 21st 2015.Protein kinase G signaling in cardiac pathophysiology: Impact of proteomics on clinical trials.Current and emerging pharmacologic options for the management of patients with chronic and acute decompensated heart failure.New pharmacological approaches in heart failure therapy: developments and possibilities.Soluble Guanylate Cyclase Stimulators: a Novel Treatment Option for Heart Failure Associated with Cardiorenal Syndromes?Novel sGC Stimulators and sGC Activators for the Treatment of Heart Failure.GRK2 as negative modulator of NO bioavailability: Implications for cardiovascular disease.Rationale and design of the SOluble guanylate Cyclase stimulatoR in heArT failurE Studies (SOCRATES).A diseasome cluster-based drug repurposing of soluble guanylate cyclase activators from smooth muscle relaxation to direct neuroprotection.Effect of Riociguat and Sildenafil on Right Heart Remodeling and Function in Pressure Overload Induced Model of Pulmonary Arterial Banding.
P2860
Q26853363-2CC43063-9BEA-4863-96DD-65F4C29AEC30Q27021649-91374CF8-4CDE-4210-B2B2-25F078530E00Q27024279-CDB908ED-80B5-444A-A79C-1615F5E52CA6Q27677544-FF4A800A-299F-4CA5-85E2-4E7AC4BD2126Q30251531-72FBF2A3-0A47-4D4C-8A80-D8BC033EA3C0Q33578212-A417C18A-AA71-4663-A11A-2AEB8D54A4ACQ35138860-3714281A-709F-4ECF-98C5-DBBD85A3B2C4Q36868978-898012B3-64F4-4D78-BE51-14155CFC69D1Q37245523-D53FBCEA-B160-482D-98A6-66FF15B9649CQ37375441-FAD9A930-7FA0-4739-8F47-9E7479EC2A95Q38161841-4D0B7A93-DD50-4394-B361-E752409CF3FBQ38214097-4F81F52F-84B9-4078-92CE-CB5CB0635F87Q38546917-2A35C6BA-DE5E-444B-8FD8-42C7739BEB39Q38558614-78659A73-14CC-49C6-B4E0-1862A261AB0EQ38594785-26E2D943-32A7-4655-8BFE-8173BCEF3737Q38612665-AC168AB0-E200-4BCD-A53E-0488171DE78BQ38670275-C9238A34-06CB-4ADD-B798-4162F1357DB8Q38737757-45CC28B2-4D06-41E8-A3D8-207DEDEC299FQ38759494-703730ED-A646-4544-88CB-0D974E81D0E9Q38818606-6C7C8B72-6146-4216-B21C-8B295F212A6BQ39024203-F62FB2BD-ADB1-4769-84B9-118131C320C9Q39080324-6F860968-78C8-475A-8CFA-D95777B3B869Q48640874-53D27CF0-B16C-45D6-B0F9-CD09E4E90884Q49718583-7970482B-739D-422D-A65C-6AB3532956DDQ52670776-46B8E9A0-44AD-417A-8E74-C96C0A9C7EF7
P2860
Soluble guanylate cyclase: a potential therapeutic target for heart failure.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Soluble guanylate cyclase: a potential therapeutic target for heart failure.
@en
type
label
Soluble guanylate cyclase: a potential therapeutic target for heart failure.
@en
prefLabel
Soluble guanylate cyclase: a potential therapeutic target for heart failure.
@en
P2093
P2860
P50
P1476
Soluble guanylate cyclase: a potential therapeutic target for heart failure.
@en
P2093
Academic Research Team in Heart Failure (ART-HF)
Adriaan A Voors
Catherine N Marti
Hani N Sabbah
John C Burnett
John G F Cleland
Lothar Roessig
Michael Böhm
Naoki Sato
Phillip D Levy
P2860
P2888
P304
P356
10.1007/S10741-012-9323-1
P50
P577
2013-03-01T00:00:00Z